Skip to content

Prevention of Postoperative Delirium Using tDCS

Prevention of Postoperative Delirium Using Transcranial Direct Current Stimulation in Patients Undergoing Cardiovascular Surgery: A Pilot Study

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs052260076
Enrollment
20
Registered
2026-06-16
Start date
2026-06-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium (following cardiovascular surgery)

Interventions

Transcranial direct current stimulation administered postoperatively

Sponsors

Kawashima Hirotsugu
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Undergoing open-heart surgery or surgery on major blood vessels - Aged 65 or older at the time consent is obtained

Exclusion criteria

Exclusion criteria: - Emergency Surgery - Patients classified as Class V on the American Society of Anesthesiologists Physical Status (ASA-PS) scale - Patients already exhibiting delirium at the time of obtaining informed consent - Patients requiring infection control measures - Patients with a possible pregnancy - Patients with epilepsy or a history thereof, a history of severe head trauma (within the past 2 years), severe mental illness, or alcohol/substance abuse (within the past 1 year) - Patients with implantable devices such as pacemakers, intracranial metal, or other metallic implants - Patients for whom electrode placement is hindered by scalp skin conditions or other factors - Patients unable to communicate sufficiently in Japanese - Cases where the estimated completion time of surgery exceeds 6:00 PM - Other study participants deemed unsuitable for the safe conduct of this study by the principal investigator or co-investigators

Design outcomes

Primary

MeasureTime frame
Incidence of delirium diagnosed by DSM-5-TR within 4 postoperative days

Secondary

MeasureTime frame
- Feasibility (consent rate, recruitment rate, protocol compliance rate, dropout rate, data collection completeness) - Safety assessment (adverse events, vital signs, ECG, skin findings) - Delirium subtypes and duration -Diagnosis and severity of delirium using various delirium assessment scales (DRS-R-98, CAM-ICU, ICDSC) - Quantitative EEG indices - Pain (NRS, CPOT-J) - Inflammation and stress markers - Changes in cognitive function (MoCA-J at 12 weeks post-surgery) - Clinical outcomes (ICU and hospital length of stay, mortality, discharge destination)

Contacts

Public ContactHirotsugu Kawashima

Kyoto University Hospital

kwsm@kuhp.kyoto-u.ac.jp+81-75-751-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026